Molecular Weight:   | 287.12 |
Volume:   | 278.122 |
LogP:   | 1.077 |
LogD:   | 1.233 |
LogS:   | -1.7 |
# Rotatable Bonds:   | 0 |
TPSA:   | 62.16 |
# H-Bond Aceptor:   | 5 |
# H-Bond Donor:   | 2 |
# Rings:   | 5 |
# Heavy Atoms:   | 5 |
QED Drug-Likeness Score:   | 0.69 |
Synthetic Accessibility Score:   | 4.165 |
Fsp3:   | 0.5 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Accepted |
GSK Rule:   | Accepted |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 0 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -4.654 |
MDCK Permeability:   | 3.0394348868867382e-05 |
Pgp-inhibitor:   | 0.004 |
Pgp-substrate:   | 0.499 |
Human Intestinal Absorption (HIA):   | 0.005 |
20% Bioavailability (F20%):   | 0.129 |
30% Bioavailability (F30%):   | 0.19 |
Blood-Brain-Barrier Penetration (BBB):   | 0.983 |
Plasma Protein Binding (PPB):   | 71.24993896484375% |
Volume Distribution (VD):   | 2.527 |
Pgp-substrate:   | 25.39485740661621% |
CYP1A2-inhibitor:   | 0.712 |
CYP1A2-substrate:   | 0.659 |
CYP2C19-inhibitor:   | 0.095 |
CYP2C19-substrate:   | 0.81 |
CYP2C9-inhibitor:   | 0.019 |
CYP2C9-substrate:   | 0.342 |
CYP2D6-inhibitor:   | 0.938 |
CYP2D6-substrate:   | 0.733 |
CYP3A4-inhibitor:   | 0.152 |
CYP3A4-substrate:   | 0.32 |
Clearance (CL):   | 16.253 |
Half-life (T1/2):   | 0.479 |
hERG Blockers:   | 0.023 |
Human Hepatotoxicity (H-HT):   | 0.057 |
Drug-inuced Liver Injury (DILI):   | 0.106 |
AMES Toxicity:   | 0.124 |
Rat Oral Acute Toxicity:   | 0.859 |
Maximum Recommended Daily Dose:   | 0.929 |
Skin Sensitization:   | 0.05 |
Carcinogencity:   | 0.945 |
Eye Corrosion:   | 0.003 |
Eye Irritation:   | 0.013 |
Respiratory Toxicity:   | 0.965 |
Natural Product ID:   | NPC181653 |
Common Name*:   | Lycorine |
IUPAC Name:   | n.a. |
Synonyms:   | GNF-Pf-4974 |
Standard InCHIKey:   | XGVJWXAYKUHDOO-DANNLKNASA-N |
Standard InCHI:   | InChI=1S/C16H17NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h3-5,11,14-16,18-19H,1-2,6-7H2/t11-,14-,15+,16+/m0/s1 |
SMILES:   | C1CN2Cc3cc4c(cc3[C@H]3[C@H]2C1=C[C@@H]([C@H]3O)O)OCO4 |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL400092 |
PubChem CID:   |
72378 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO33213 | narcissus incomparabilis | Species | Amaryllidaceae | Eukaryota | bulbs | n.a. | n.a. |
PMID[1336040] |
NPO23263 | Crinum yemense | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[15270564] |
NPO22974 | Hosta plantaginea | Species | Asparagaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[17822295] |
NPO33543 | Brunsvigia littoralis | Species | Amaryllidaceae | Eukaryota | bulbs | n.a. | n.a. |
PMID[19299148] |
NPO13784 | Dalbergia candenatensis | Species | Fabaceae | Eukaryota | heartwood | n.a. | n.a. |
PMID[19653666] |
NPO12711 | Ligularia altaica | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[20073490] |
NPO9927.2 | Crinum asiaticum var. sinicum | Varieties | Amaryllidaceae | Eukaryota | n.a. | bulb | n.a. |
PMID[21314165] |
NPO9927.2 | Crinum asiaticum var. sinicum | Varieties | Amaryllidaceae | Eukaryota | n.a. | leaf | n.a. |
PMID[21314165] |
NPO40778 | Alkaloid lycorine | Species | n.a. | n.a. | n.a. | n.a. | n.a. |
PMID[22019045] |
NPO33437 | amaryllidaceae | Family | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[22921081] |
NPO10671 | Zephyranthes candida | Species | Amaryllidaceae | Eukaryota | n.a. | whole plant | n.a. |
PMID[23190013] |
NPO10671 | Zephyranthes candida | Species | Amaryllidaceae | Eukaryota | whole plants | n.a. | n.a. |
PMID[23190013] |
NPO22157 | Datura wrightii | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[23252848] |
NPO10671 | Zephyranthes candida | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[2348199] |
NPO16709 | Clivia miniata | Species | Amaryllidaceae | Eukaryota | n.a. | leaf | n.a. |
PMID[24221429] |
NPO10671 | Zephyranthes candida | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[26913788] |
NPO40160 | Hippeastrum argentinum | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[27096334] |
NPO4576 | Corynandra viscosa | Species | Cleomaceae | Eukaryota | n.a. | leaf | n.a. |
PMID[28135851] |
NPO23000 | Zephyranthes carinata | Species | Amaryllidaceae | Eukaryota | Whole Plants | n.a. | n.a. |
PMID[28898076] |
NPO13784 | Dalbergia candenatensis | Species | Fabaceae | Eukaryota | n.a. | Thai | n.a. |
PMID[3430167] |
NPO16709 | Clivia miniata | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[7153775] |
NPO22317 | Crinum amabile | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[8229016] |
NPO30214 | Pericarpium citri | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
NPO22317 | Crinum amabile | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO16709 | Clivia miniata | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO10671 | Zephyranthes candida | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO9927.2 | Crinum asiaticum var. sinicum | Varieties | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO22054 | Cinchona officinalis | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO16709 | Clivia miniata | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO22054 | Cinchona officinalis | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO1383.1 | Murraya paniculata var. omphalocarpa | Varieties | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO4576 | Corynandra viscosa | Species | Cleomaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO22317 | Crinum amabile | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO10671 | Zephyranthes candida | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO27662 | Pericarpium citri reticulatae viride | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO9927.2 | Crinum asiaticum var. sinicum | Varieties | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO389 | Actaea heracleifolia | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO10671 | Zephyranthes candida | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO389 | Actaea heracleifolia | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO7031 | Salvia keerlii | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO22974 | Hosta plantaginea | Species | Asparagaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO389 | Actaea heracleifolia | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO9612 | Dryopteris dilatata | Species | Dryopteridaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO13659 | Helichrysum asperum | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25680 | Ramalina siliquosa | Species | Ramalinaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO23120 | Clausena suffruticosa | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO17432 | Ligularia przewalskii | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO13181 | Ferula persica | Species | Apiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO22157 | Datura wrightii | Species | Solanaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO12711 | Ligularia altaica | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO1828 | Searsia leptodictya | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO23000 | Zephyranthes carinata | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8546 | Corydalis chaerophylla | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO22054 | Cinchona officinalis | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO23036 | Angelica hirsutiflora | Species | Apiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO4576 | Corynandra viscosa | Species | Cleomaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO22317 | Crinum amabile | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO26299 | Reticularia lycoperdon | Species | Reticulariaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO22009 | Lupinus holosericeus | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO16709 | Clivia miniata | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO19610 | Stachys aegyptiaca | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO23263 | Crinum yemense | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO18476 | Lophopetalum toxicum | Species | Celastraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO10319 | Calycodendron milnei | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[UNPD] |
NPO10671 | Zephyranthes candida | Species | Amaryllidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO1383.1 | Murraya paniculata var. omphalocarpa | Varieties | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO21442 | Elaeocarpus sphaericus | Species | Elaeocarpaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO20170 | Anthoceros punctatus | Species | Anthocerotaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO4316 | Ananas sativus | Species | Bromeliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO13784 | Dalbergia candenatensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | IC50 | = | 155000.0 | nM | PMID[486089] |
NPT168 | Cell Line | P388 | Mus musculus | T/C | = | 135.0 | % | PMID[486091] |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | ED50 | = | 1.6 | ug ml-1 | PMID[486095] |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | = | 0.3 | ug ml-1 | PMID[486095] |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 0.9 | ug ml-1 | PMID[486095] |
NPT762 | Cell Line | A-431 | Homo sapiens | ED50 | = | 1.3 | ug ml-1 | PMID[486095] |
NPT858 | Cell Line | LNCaP | Homo sapiens | ED50 | = | 0.5 | ug ml-1 | PMID[486095] |
NPT133 | Cell Line | ZR-75-1 | Homo sapiens | ED50 | = | 0.9 | ug ml-1 | PMID[486095] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | ED50 | = | 0.5 | ug ml-1 | PMID[486095] |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 4300.0 | nM | PMID[486098] |
NPT169 | Cell Line | B16-F10 | Mus musculus | IC50 | = | 6300.0 | nM | PMID[486098] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | IC50 | = | 8500.0 | nM | PMID[486098] |
NPT3190 | Cell Line | NHDF | Homo sapiens | IC50 | > | 100000.0 | nM | PMID[486098] |
NPT81 | Cell Line | A549 | Homo sapiens | Activity | >= | 90.0 | % | PMID[486098] |
NPT169 | Cell Line | B16-F10 | Mus musculus | MTD | = | 40.0 | mg kg-1 | PMID[486098] |
NPT1229 | Cell Line | Huh-7 | Homo sapiens | CC50 | = | 66120.0 | nM | PMID[486099] |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 2000.0 | nM | PMID[486100] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | IC50 | = | 2000.0 | nM | PMID[486100] |
NPT5027 | Cell Line | Hs 683 | Homo sapiens | IC50 | = | 2000.0 | nM | PMID[486100] |
NPT169 | Cell Line | B16-F10 | Mus musculus | IC50 | = | 2000.0 | nM | PMID[486100] |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 4200.0 | nM | PMID[486101] |
NPT916 | Cell Line | SK-MEL | Homo sapiens | IC50 | = | 8400.0 | nM | PMID[486101] |
NPT169 | Cell Line | B16-F10 | Mus musculus | IC50 | = | 6300.0 | nM | PMID[486101] |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | n.a. | 10000.0 | nM | PMID[486105] |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 4000.0 | nM | PMID[486107] |
NPT169 | Cell Line | B16-F10 | Mus musculus | GI50 | = | 2000.0 | nM | PMID[486107] |
NPT1125 | Cell Line | T98G | Homo sapiens | GI50 | = | 3000.0 | nM | PMID[486107] |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | = | 900.0 | nM | PMID[486107] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | = | 4000.0 | nM | PMID[486107] |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | = | 4000.0 | nM | PMID[486107] |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | n.a. | 2594.18 | nM | PMID[486109] |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | n.a. | 1702.16 | nM | PMID[486109] |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | n.a. | 849.18 | nM | PMID[486109] |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | n.a. | 2421.03 | nM | PMID[486109] |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | n.a. | 1472.31 | nM | PMID[486109] |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | n.a. | 2142.89 | nM | PMID[486109] |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | n.a. | 1324.34 | nM | PMID[486109] |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | n.a. | 1803.02 | nM | PMID[486109] |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | n.a. | 1415.79 | nM | PMID[486109] |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | n.a. | 1923.09 | nM | PMID[486109] |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | n.a. | 2964.83 | nM | PMID[486109] |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | n.a. | 1196.74 | nM | PMID[486109] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | n.a. | 2471.72 | nM | PMID[486109] |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | n.a. | 1294.2 | nM | PMID[486109] |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | n.a. | 2312.06 | nM | PMID[486109] |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | n.a. | 1778.28 | nM | PMID[486109] |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | n.a. | 1990.67 | nM | PMID[486109] |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | n.a. | 1531.09 | nM | PMID[486109] |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | n.a. | 2500.35 | nM | PMID[486109] |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | n.a. | 2108.63 | nM | PMID[486109] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | n.a. | 1648.16 | nM | PMID[486109] |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | n.a. | 1468.93 | nM | PMID[486109] |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | n.a. | 2673.01 | nM | PMID[486109] |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | n.a. | 2612.16 | nM | PMID[486109] |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | n.a. | 1051.96 | nM | PMID[486109] |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | n.a. | 2703.96 | nM | PMID[486109] |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | n.a. | 1862.09 | nM | PMID[486109] |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | n.a. | 1432.19 | nM | PMID[486109] |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | n.a. | 2009.09 | nM | PMID[486109] |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | n.a. | 1336.6 | nM | PMID[486109] |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | n.a. | 970.51 | nM | PMID[486109] |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | n.a. | 1663.41 | nM | PMID[486109] |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | n.a. | 375.84 | nM | PMID[486109] |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | n.a. | 2328.09 | nM | PMID[486109] |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | n.a. | 1389.95 | nM | PMID[486109] |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | n.a. | 3133.29 | nM | PMID[486109] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | n.a. | 1261.83 | nM | PMID[486109] |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | n.a. | 1327.39 | nM | PMID[486109] |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | n.a. | 2393.32 | nM | PMID[486109] |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | n.a. | 801.68 | nM | PMID[486109] |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | n.a. | 1445.44 | nM | PMID[486109] |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | n.a. | 201.37 | nM | PMID[486109] |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | n.a. | 1840.77 | nM | PMID[486109] |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | n.a. | 2488.86 | nM | PMID[486109] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | n.a. | 1264.74 | nM | PMID[486109] |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | n.a. | 2079.7 | nM | PMID[486109] |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | n.a. | 2070.14 | nM | PMID[486109] |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | n.a. | 1244.51 | nM | PMID[486109] |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | n.a. | 331.89 | nM | PMID[486109] |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | n.a. | 2685.34 | nM | PMID[486109] |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | n.a. | 3104.56 | nM | PMID[486109] |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | n.a. | 2910.72 | nM | PMID[486109] |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | n.a. | 650.13 | nM | PMID[486109] |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | n.a. | 1823.9 | nM | PMID[486109] |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | n.a. | 1458.81 | nM | PMID[486109] |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | n.a. | 2760.58 | nM | PMID[486109] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | n.a. | 2697.74 | nM | PMID[486109] |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | n.a. | 299.92 | nM | PMID[486109] |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | n.a. | 1253.14 | nM | PMID[486109] |
NPT1160 | Cell Line | BJ | Homo sapiens | IC50 | = | 1900.0 | nM | PMID[486110] |
NPT2468 | Cell Line | G-361 | Homo sapiens | IC50 | = | 5000.0 | nM | PMID[486110] |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 10600.0 | nM | PMID[486110] |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 13000.0 | nM | PMID[486110] |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | = | 3600.0 | nM | PMID[486110] |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | IC50 | = | 1600.0 | nM | PMID[486110] |
NPT139 | Cell Line | HT-29 | Homo sapiens | Ratio IC50 | = | 10.0 | n.a. | PMID[486111] |
NPT65 | Cell Line | HepG2 | Homo sapiens | Ratio IC50 | = | 10.0 | n.a. | PMID[486111] |
NPT81 | Cell Line | A549 | Homo sapiens | Ratio IC50 | = | 10.0 | n.a. | PMID[486111] |
NPT111 | Cell Line | K562 | Homo sapiens | Ratio IC50 | = | 10.0 | n.a. | PMID[486111] |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 3200.0 | nM | PMID[486111] |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 3700.0 | nM | PMID[486111] |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 1900.0 | nM | PMID[486111] |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | = | 2300.0 | nM | PMID[486111] |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 1600.0 | nM | PMID[486111] |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 10900.0 | nM | PMID[486113] |
NPT1125 | Cell Line | T98G | Homo sapiens | GI50 | = | 5200.0 | nM | PMID[486113] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | = | 3700.0 | nM | PMID[486113] |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | = | 3000.0 | nM | PMID[486113] |
NPT169 | Cell Line | B16-F10 | Mus musculus | GI50 | = | 2600.0 | nM | PMID[486113] |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | IC50 | > | 200000.0 | nM | PMID[486114] |
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | IC50 | > | 200000.0 | nM | PMID[486116] |
NPT2846 | Cell Line | BHK-21 | Cricetulus griseus | CC50 | = | 4370.0 | nM | PMID[486122] |
NPT2679 | Cell Line | LLC-MK2 | Macaca mulatta | CC50 | = | 3810.0 | nM | PMID[486122] |
NPT2 | Others | Unspecified | Inhibition | = | 0.0 | % | PMID[486090] | |
NPT27 | Others | Unspecified | Activity | = | 98.2 | % | PMID[486090] | |
NPT2 | Others | Unspecified | Inhibition | = | 2.8 | % | PMID[486090] | |
NPT27 | Others | Unspecified | Activity | = | 101.4 | % | PMID[486090] | |
NPT2 | Others | Unspecified | Inhibition | = | 20.6 | % | PMID[486090] | |
NPT27 | Others | Unspecified | Activity | = | 105.4 | % | PMID[486090] | |
NPT2 | Others | Unspecified | Inhibition | = | 54.4 | % | PMID[486090] | |
NPT27 | Others | Unspecified | Activity | = | 98.3 | % | PMID[486090] | |
NPT2 | Others | Unspecified | Inhibition | = | 91.4 | % | PMID[486090] | |
NPT27 | Others | Unspecified | Activity | = | 76.1 | % | PMID[486090] | |
NPT2 | Others | Unspecified | IC50 | = | 2500.0 | nM | PMID[486090] | |
NPT5025 | Organism | Solanum tuberosum | Solanum tuberosum | Inhibition | = | 80.0 | % | PMID[486092] |
NPT27 | Others | Unspecified | TI | = | 10.0 | n.a. | PMID[486093] | |
NPT1047 | Organism | Simplexvirus | Simplexvirus | pTCD50 | = | 1000.0 | n.a. | PMID[486093] |
NPT1047 | Organism | Simplexvirus | Simplexvirus | pTCD50 | = | 100.0 | n.a. | PMID[486093] |
NPT856 | Organism | Semliki forest virus | Semliki forest virus | pTCD50 | = | 10000.0 | n.a. | PMID[486093] |
NPT856 | Organism | Semliki forest virus | Semliki forest virus | pTCD50 | = | 1000.0 | n.a. | PMID[486093] |
NPT856 | Organism | Semliki forest virus | Semliki forest virus | pTCD50 | = | 100.0 | n.a. | PMID[486093] |
NPT1048 | Organism | Poliovirus | Human enterovirus C | pTCD50 | = | 10000.0 | n.a. | PMID[486093] |
NPT1048 | Organism | Poliovirus | Human enterovirus C | pTCD50 | = | 1000.0 | n.a. | PMID[486093] |
NPT1048 | Organism | Poliovirus | Human enterovirus C | pTCD50 | = | 100.0 | n.a. | PMID[486093] |
NPT1049 | Organism | Measles virus | Measles virus | pTCD50 | = | 1000.0 | n.a. | PMID[486093] |
NPT1049 | Organism | Measles virus | Measles virus | pTCD50 | = | 100.0 | n.a. | PMID[486093] |
NPT5026 | Organism | Rhodococcus fascians | Rhodococcus fascians | IZ | = | 0.0 | mm | PMID[486094] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | ED50 | = | 0.9 | ug ml-1 | PMID[486095] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | ED50 | = | 0.8 | ug ml-1 | PMID[486095] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | ED50 | = | 0.4 | ug ml-1 | PMID[486095] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | ED50 | = | 0.3 | ug ml-1 | PMID[486095] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 320.0 | ug ml-1 | PMID[486095] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 300.0 | ug ml-1 | PMID[486095] |
NPT2 | Others | Unspecified | Ratio ED50 | = | 1.0 | n.a. | PMID[486095] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | ED50 | = | 1.6 | ug ml-1 | PMID[486095] |
NPT33 | Organism | Japanese encephalitis virus | Japanese encephalitis virus | IC50 | = | 0.33 | ug.mL-1 | PMID[486096] |
NPT4327 | Organism | Yellow fever virus | Yellow fever virus | IC50 | = | 0.28 | ug.mL-1 | PMID[486096] |
NPT4328 | Organism | Dengue virus type 4 | Dengue virus 4 | IC50 | = | 0.24 | ug.mL-1 | PMID[486096] |
NPT27 | Others | Unspecified | TI | = | 8.2 | n.a. | PMID[486096] | |
NPT27 | Others | Unspecified | TI | = | 7.3 | n.a. | PMID[486096] | |
NPT27 | Others | Unspecified | TI | = | 10.4 | n.a. | PMID[486096] | |
NPT341 | Organism | Punta Toro virus | Punta Toro virus | IC50 | = | 0.5 | ug.mL-1 | PMID[486096] |
NPT4329 | Organism | Rift Valley fever virus | Rift Valley fever virus | IC50 | = | 0.93 | ug.mL-1 | PMID[486096] |
NPT27 | Others | Unspecified | TI | = | 4.6 | n.a. | PMID[486096] | |
NPT27 | Others | Unspecified | TI | = | 5.4 | n.a. | PMID[486096] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 5100.0 | nM | PMID[486098] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 6700.0 | nM | PMID[486098] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 7600.0 | nM | PMID[486098] |
NPT27 | Others | Unspecified | IC50 | > | 100000.0 | nM | PMID[486098] | |
NPT2 | Others | Unspecified | Activity | >= | 90.0 | % | PMID[486098] | |
NPT32 | Organism | Mus musculus | Mus musculus | MTD | = | 80.0 | mg kg-1 | PMID[486098] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | EC50 | = | 156.2 | nM | PMID[486099] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | EC50 | = | 607.0 | nM | PMID[486099] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 2000.0 | nM | PMID[486100] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 4500.0 | nM | PMID[486101] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 6900.0 | nM | PMID[486101] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 7600.0 | nM | PMID[486101] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.62 | ug.mL-1 | PMID[486102] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 130.0 | nM | PMID[486103] |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 1122.0 | nM | PMID[486105] |
NPT2 | Others | Unspecified | Potency | = | 3162.3 | nM | PMID[486105] | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | n.a. | 4744.4 | nM | PMID[486105] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | GI50 | = | 900.0 | nM | PMID[486107] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | GI50 | = | 3000.0 | nM | PMID[486107] |
NPT3041 | Organism | Human enterovirus 71 | Human enterovirus 71 | Activity | = | 18.0 | % | PMID[486108] |
NPT2 | Others | Unspecified | Ratio IC50 | = | 10.0 | n.a. | PMID[486111] | |
NPT27 | Others | Unspecified | IC50 | = | 4900.0 | nM | PMID[486111] | |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 60.96 | % | PMID[486112] |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 97.14 | % | PMID[486112] |
NPT35 | Others | n.a. | LogP | = | -0.78 | n.a. | PMID[486113] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | GI50 | = | 2100.0 | nM | PMID[486113] |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | IC50 | > | 200000.0 | nM | PMID[486114] |
NPT19 | Organism | Escherichia coli | Escherichia coli | IZ | = | 13.0 | mm | PMID[486117] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | IZ | = | 15.0 | mm | PMID[486117] |
NPT5026 | Organism | Rhodococcus fascians | Rhodococcus fascians | IZ | = | 0.0 | mm | PMID[486117] |
NPT25178 | ORGANISM | Edwardsiella ictaluri | Edwardsiella ictaluri | MIC | > | 287.0 | ug.mL-1 | PMID[486117] |
NPT24393 | ORGANISM | Flavobacterium columnare | Flavobacterium columnare | MIC | = | 100000.0 | nM | PMID[486117] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 287.0 | ug.mL-1 | PMID[486117] |
NPT3041 | Organism | Human enterovirus 71 | Human enterovirus 71 | Survival | = | 30.0 | % | PMID[486118] |
NPT1019 | Organism | Trichomonas vaginalis | Trichomonas vaginalis | Activity | = | 40.0 | % | PMID[486119] |
NPT1019 | Organism | Trichomonas vaginalis | Trichomonas vaginalis | Activity | = | 20.0 | % | PMID[486119] |
NPT992 | Organism | Entamoeba histolytica | Entamoeba histolytica | IC50 | = | 0.23 | ug.mL-1 | PMID[486119] |
NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | IC50 | = | 3.1 | ug.mL-1 | PMID[486119] |
NPT1724 | Organism | Dengue virus | Dengue virus | EC50 | = | 400.0 | nM | PMID[486120] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | PMID[486121] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | PMID[486121] |
NPT2 | Others | Unspecified | EC50 | = | 150.0 | nM | PMID[486122] | |
NPT2 | Others | Unspecified | Ratio CC50/EC50 | = | 29.1 | n.a. | PMID[486122] | |
NPT24755 | ORGANISM | SARS-CoV | Severe acute respiratory syndrome-related coronavirus | IC50 | = | 15.7 | nM | PMID[486122] |
NPT22224 | CELL-LINE | Vero C1008 | Chlorocebus sabaeus | CC50 | = | 14900.0 | nM | PMID[486122] |
NPT2 | Others | Unspecified | Ratio CC50/EC50 | = | 954.0 | n.a. | PMID[486122] | |
NPT2 | Others | Unspecified | EC50 | = | 470.0 | nM | PMID[486122] | |
NPT2 | Others | Unspecified | Ratio CC50/EC50 | = | 8.11 | n.a. | PMID[486122] | |
NPT2 | Others | Unspecified | Activity | = | 83.3 | % | PMID[486122] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC181653 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC190332 |
0.9805 | High Similarity | NPC320104 |
0.9744 | High Similarity | NPC100566 |
0.9625 | High Similarity | NPC237044 |
0.9565 | High Similarity | NPC474325 |
0.9563 | High Similarity | NPC304675 |
0.9506 | High Similarity | NPC474745 |
0.9434 | High Similarity | NPC58766 |
0.9434 | High Similarity | NPC475686 |
0.9375 | High Similarity | NPC474475 |
0.9375 | High Similarity | NPC311991 |
0.9333 | High Similarity | NPC475981 |
0.9333 | High Similarity | NPC474746 |
0.9317 | High Similarity | NPC477640 |
0.9317 | High Similarity | NPC470739 |
0.9317 | High Similarity | NPC225597 |
0.9313 | High Similarity | NPC82533 |
0.9313 | High Similarity | NPC290759 |
0.9313 | High Similarity | NPC266176 |
0.9313 | High Similarity | NPC158148 |
0.9299 | High Similarity | NPC205167 |
0.9299 | High Similarity | NPC215829 |
0.9299 | High Similarity | NPC97072 |
0.9299 | High Similarity | NPC249274 |
0.925 | High Similarity | NPC57812 |
0.925 | High Similarity | NPC474324 |
0.9222 | High Similarity | NPC230098 |
0.9202 | High Similarity | NPC187678 |
0.9193 | High Similarity | NPC475845 |
0.9187 | High Similarity | NPC476002 |
0.9177 | High Similarity | NPC4304 |
0.9136 | High Similarity | NPC474708 |
0.9091 | High Similarity | NPC294790 |
0.9091 | High Similarity | NPC15919 |
0.9091 | High Similarity | NPC148693 |
0.9091 | High Similarity | NPC118633 |
0.903 | High Similarity | NPC474470 |
0.8924 | High Similarity | NPC78733 |
0.8922 | High Similarity | NPC244554 |
0.8817 | High Similarity | NPC275132 |
0.8795 | High Similarity | NPC2314 |
0.8788 | High Similarity | NPC75958 |
0.878 | High Similarity | NPC252960 |
0.8773 | High Similarity | NPC247972 |
0.875 | High Similarity | NPC147091 |
0.8735 | High Similarity | NPC65403 |
0.8713 | High Similarity | NPC9867 |
0.8712 | High Similarity | NPC218614 |
0.8679 | High Similarity | NPC223124 |
0.8679 | High Similarity | NPC148898 |
0.8642 | High Similarity | NPC59028 |
0.8642 | High Similarity | NPC92191 |
0.8642 | High Similarity | NPC111485 |
0.8631 | High Similarity | NPC199465 |
0.8631 | High Similarity | NPC229166 |
0.8631 | High Similarity | NPC128560 |
0.8631 | High Similarity | NPC49353 |
0.8596 | High Similarity | NPC248642 |
0.8588 | High Similarity | NPC126284 |
0.8562 | High Similarity | NPC233029 |
0.8562 | High Similarity | NPC210148 |
0.8554 | High Similarity | NPC210918 |
0.8553 | High Similarity | NPC274026 |
0.8553 | High Similarity | NPC223125 |
0.8547 | High Similarity | NPC156576 |
0.8545 | High Similarity | NPC238530 |
0.8545 | High Similarity | NPC232514 |
0.8545 | High Similarity | NPC276944 |
0.8545 | High Similarity | NPC180306 |
0.8544 | High Similarity | NPC475959 |
0.8529 | High Similarity | NPC320223 |
0.8529 | High Similarity | NPC114364 |
0.8519 | High Similarity | NPC234392 |
0.8519 | High Similarity | NPC31311 |
0.8476 | Intermediate Similarity | NPC165797 |
0.8475 | Intermediate Similarity | NPC33256 |
0.8447 | Intermediate Similarity | NPC82285 |
0.8447 | Intermediate Similarity | NPC133011 |
0.8443 | Intermediate Similarity | NPC150879 |
0.8443 | Intermediate Similarity | NPC301189 |
0.8443 | Intermediate Similarity | NPC298186 |
0.8434 | Intermediate Similarity | NPC302527 |
0.8434 | Intermediate Similarity | NPC167546 |
0.8434 | Intermediate Similarity | NPC16805 |
0.8415 | Intermediate Similarity | NPC477080 |
0.8405 | Intermediate Similarity | NPC146288 |
0.8383 | Intermediate Similarity | NPC24264 |
0.8383 | Intermediate Similarity | NPC476432 |
0.8382 | Intermediate Similarity | NPC233718 |
0.8382 | Intermediate Similarity | NPC116284 |
0.8363 | Intermediate Similarity | NPC283999 |
0.8344 | Intermediate Similarity | NPC216459 |
0.8344 | Intermediate Similarity | NPC41178 |
0.8344 | Intermediate Similarity | NPC138487 |
0.8343 | Intermediate Similarity | NPC214116 |
0.8333 | Intermediate Similarity | NPC298979 |
0.8333 | Intermediate Similarity | NPC247389 |
0.8324 | Intermediate Similarity | NPC477561 |
0.8324 | Intermediate Similarity | NPC476574 |
0.8324 | Intermediate Similarity | NPC155442 |
0.8324 | Intermediate Similarity | NPC312918 |
0.8323 | Intermediate Similarity | NPC225774 |
0.8323 | Intermediate Similarity | NPC231198 |
0.8313 | Intermediate Similarity | NPC246587 |
0.8313 | Intermediate Similarity | NPC428 |
0.8313 | Intermediate Similarity | NPC147390 |
0.8313 | Intermediate Similarity | NPC24233 |
0.8313 | Intermediate Similarity | NPC135538 |
0.8313 | Intermediate Similarity | NPC476571 |
0.8303 | Intermediate Similarity | NPC69360 |
0.8294 | Intermediate Similarity | NPC57272 |
0.8276 | Intermediate Similarity | NPC476575 |
0.8274 | Intermediate Similarity | NPC219341 |
0.8266 | Intermediate Similarity | NPC99179 |
0.8263 | Intermediate Similarity | NPC233650 |
0.825 | Intermediate Similarity | NPC179825 |
0.825 | Intermediate Similarity | NPC191376 |
0.825 | Intermediate Similarity | NPC321505 |
0.8239 | Intermediate Similarity | NPC130926 |
0.8239 | Intermediate Similarity | NPC185838 |
0.8229 | Intermediate Similarity | NPC135772 |
0.8225 | Intermediate Similarity | NPC210140 |
0.8214 | Intermediate Similarity | NPC196447 |
0.8214 | Intermediate Similarity | NPC306843 |
0.8214 | Intermediate Similarity | NPC212794 |
0.8214 | Intermediate Similarity | NPC96603 |
0.8214 | Intermediate Similarity | NPC13504 |
0.8214 | Intermediate Similarity | NPC136508 |
0.8214 | Intermediate Similarity | NPC78222 |
0.8214 | Intermediate Similarity | NPC477563 |
0.8214 | Intermediate Similarity | NPC134858 |
0.8214 | Intermediate Similarity | NPC253043 |
0.821 | Intermediate Similarity | NPC97221 |
0.821 | Intermediate Similarity | NPC151895 |
0.821 | Intermediate Similarity | NPC192768 |
0.821 | Intermediate Similarity | NPC220858 |
0.821 | Intermediate Similarity | NPC88249 |
0.8198 | Intermediate Similarity | NPC477558 |
0.8194 | Intermediate Similarity | NPC7018 |
0.8187 | Intermediate Similarity | NPC19520 |
0.8187 | Intermediate Similarity | NPC149090 |
0.8166 | Intermediate Similarity | NPC124657 |
0.8155 | Intermediate Similarity | NPC324144 |
0.8155 | Intermediate Similarity | NPC59567 |
0.8148 | Intermediate Similarity | NPC477565 |
0.8148 | Intermediate Similarity | NPC103379 |
0.8146 | Intermediate Similarity | NPC82763 |
0.8144 | Intermediate Similarity | NPC477559 |
0.8144 | Intermediate Similarity | NPC232924 |
0.8144 | Intermediate Similarity | NPC160298 |
0.8144 | Intermediate Similarity | NPC306902 |
0.8144 | Intermediate Similarity | NPC266753 |
0.8137 | Intermediate Similarity | NPC476151 |
0.8133 | Intermediate Similarity | NPC475326 |
0.8129 | Intermediate Similarity | NPC6152 |
0.8121 | Intermediate Similarity | NPC76079 |
0.8121 | Intermediate Similarity | NPC249797 |
0.8121 | Intermediate Similarity | NPC278799 |
0.8121 | Intermediate Similarity | NPC5238 |
0.8121 | Intermediate Similarity | NPC110416 |
0.8121 | Intermediate Similarity | NPC295691 |
0.8121 | Intermediate Similarity | NPC469817 |
0.8121 | Intermediate Similarity | NPC193949 |
0.8121 | Intermediate Similarity | NPC54379 |
0.8121 | Intermediate Similarity | NPC39701 |
0.8121 | Intermediate Similarity | NPC207757 |
0.8121 | Intermediate Similarity | NPC172765 |
0.8121 | Intermediate Similarity | NPC127674 |
0.8121 | Intermediate Similarity | NPC184026 |
0.8121 | Intermediate Similarity | NPC189266 |
0.8121 | Intermediate Similarity | NPC276588 |
0.8121 | Intermediate Similarity | NPC204828 |
0.8121 | Intermediate Similarity | NPC2413 |
0.8118 | Intermediate Similarity | NPC158376 |
0.8118 | Intermediate Similarity | NPC12053 |
0.8118 | Intermediate Similarity | NPC117188 |
0.8118 | Intermediate Similarity | NPC205421 |
0.8118 | Intermediate Similarity | NPC306555 |
0.8118 | Intermediate Similarity | NPC145832 |
0.8118 | Intermediate Similarity | NPC474931 |
0.8118 | Intermediate Similarity | NPC81218 |
0.8107 | Intermediate Similarity | NPC24465 |
0.8101 | Intermediate Similarity | NPC188163 |
0.8101 | Intermediate Similarity | NPC213206 |
0.8101 | Intermediate Similarity | NPC328750 |
0.8101 | Intermediate Similarity | NPC474915 |
0.809 | Intermediate Similarity | NPC186546 |
0.809 | Intermediate Similarity | NPC476576 |
0.8086 | Intermediate Similarity | NPC37144 |
0.8086 | Intermediate Similarity | NPC59907 |
0.8072 | Intermediate Similarity | NPC186063 |
0.807 | Intermediate Similarity | NPC160570 |
0.8068 | Intermediate Similarity | NPC102760 |
0.8065 | Intermediate Similarity | NPC80472 |
0.8059 | Intermediate Similarity | NPC13916 |
0.8059 | Intermediate Similarity | NPC264850 |
0.8057 | Intermediate Similarity | NPC32154 |
0.8056 | Intermediate Similarity | NPC117717 |
0.8046 | Intermediate Similarity | NPC241704 |
0.8038 | Intermediate Similarity | NPC314682 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC181653 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8333 | Intermediate Similarity | NPD2970 | Approved |
0.8333 | Intermediate Similarity | NPD2969 | Approved |
0.8282 | Intermediate Similarity | NPD4773 | Phase 2 |
0.8282 | Intermediate Similarity | NPD4772 | Phase 2 |
0.8176 | Intermediate Similarity | NPD2489 | Approved |
0.8176 | Intermediate Similarity | NPD27 | Approved |
0.8166 | Intermediate Similarity | NPD3051 | Approved |
0.8101 | Intermediate Similarity | NPD4664 | Clinical (unspecified phase) |
0.8063 | Intermediate Similarity | NPD5084 | Clinical (unspecified phase) |
0.8059 | Intermediate Similarity | NPD6071 | Discontinued |
0.8024 | Intermediate Similarity | NPD2563 | Approved |
0.8024 | Intermediate Similarity | NPD2560 | Approved |
0.7914 | Intermediate Similarity | NPD4584 | Approved |
0.7861 | Intermediate Similarity | NPD4481 | Phase 3 |
0.7857 | Intermediate Similarity | NPD6818 | Clinical (unspecified phase) |
0.7857 | Intermediate Similarity | NPD2977 | Approved |
0.7857 | Intermediate Similarity | NPD2978 | Approved |
0.7809 | Intermediate Similarity | NPD7311 | Approved |
0.7809 | Intermediate Similarity | NPD7313 | Approved |
0.7809 | Intermediate Similarity | NPD7312 | Approved |
0.7809 | Intermediate Similarity | NPD7310 | Approved |
0.7778 | Intermediate Similarity | NPD4663 | Approved |
0.7765 | Intermediate Similarity | NPD7309 | Approved |
0.7759 | Intermediate Similarity | NPD2898 | Approved |
0.773 | Intermediate Similarity | NPD5241 | Discontinued |
0.7716 | Intermediate Similarity | NPD4237 | Approved |
0.7716 | Intermediate Similarity | NPD4236 | Phase 3 |
0.7711 | Intermediate Similarity | NPD3639 | Approved |
0.7711 | Intermediate Similarity | NPD3641 | Approved |
0.7711 | Intermediate Similarity | NPD3640 | Phase 3 |
0.7709 | Intermediate Similarity | NPD7280 | Phase 3 |
0.7709 | Intermediate Similarity | NPD7281 | Phase 3 |
0.7709 | Intermediate Similarity | NPD4578 | Approved |
0.7709 | Intermediate Similarity | NPD4577 | Approved |
0.7705 | Intermediate Similarity | NPD7296 | Approved |
0.7688 | Intermediate Similarity | NPD6107 | Approved |
0.7683 | Intermediate Similarity | NPD6783 | Clinical (unspecified phase) |
0.7676 | Intermediate Similarity | NPD5582 | Discontinued |
0.7647 | Intermediate Similarity | NPD5772 | Approved |
0.7647 | Intermediate Similarity | NPD5773 | Approved |
0.7644 | Intermediate Similarity | NPD4010 | Discontinued |
0.7637 | Intermediate Similarity | NPD7906 | Approved |
0.7616 | Intermediate Similarity | NPD5604 | Discontinued |
0.7594 | Intermediate Similarity | NPD4420 | Approved |
0.7588 | Intermediate Similarity | NPD7298 | Approved |
0.7569 | Intermediate Similarity | NPD8053 | Approved |
0.7569 | Intermediate Similarity | NPD8054 | Approved |
0.7569 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7526 | Intermediate Similarity | NPD5006 | Approved |
0.7526 | Intermediate Similarity | NPD5005 | Approved |
0.7515 | Intermediate Similarity | NPD4017 | Approved |
0.7514 | Intermediate Similarity | NPD7831 | Phase 2 |
0.7514 | Intermediate Similarity | NPD7832 | Clinical (unspecified phase) |
0.7514 | Intermediate Similarity | NPD7833 | Phase 2 |
0.7485 | Intermediate Similarity | NPD1754 | Clinical (unspecified phase) |
0.7468 | Intermediate Similarity | NPD2669 | Clinical (unspecified phase) |
0.7456 | Intermediate Similarity | NPD4210 | Discontinued |
0.7446 | Intermediate Similarity | NPD7243 | Clinical (unspecified phase) |
0.7443 | Intermediate Similarity | NPD4166 | Phase 2 |
0.743 | Intermediate Similarity | NPD5312 | Approved |
0.743 | Intermediate Similarity | NPD8156 | Discontinued |
0.743 | Intermediate Similarity | NPD5313 | Approved |
0.7429 | Intermediate Similarity | NPD7201 | Clinical (unspecified phase) |
0.7396 | Intermediate Similarity | NPD6031 | Approved |
0.7396 | Intermediate Similarity | NPD6030 | Approved |
0.7374 | Intermediate Similarity | NPD8099 | Discontinued |
0.7374 | Intermediate Similarity | NPD8251 | Approved |
0.7374 | Intermediate Similarity | NPD8252 | Approved |
0.7366 | Intermediate Similarity | NPD2488 | Approved |
0.7366 | Intermediate Similarity | NPD2490 | Approved |
0.736 | Intermediate Similarity | NPD7827 | Phase 1 |
0.7289 | Intermediate Similarity | NPD5177 | Phase 3 |
0.7289 | Intermediate Similarity | NPD3060 | Approved |
0.7277 | Intermediate Similarity | NPD7237 | Clinical (unspecified phase) |
0.7267 | Intermediate Similarity | NPD554 | Clinical (unspecified phase) |
0.7262 | Intermediate Similarity | NPD2422 | Clinical (unspecified phase) |
0.7257 | Intermediate Similarity | NPD6788 | Approved |
0.7228 | Intermediate Similarity | NPD2968 | Approved |
0.7228 | Intermediate Similarity | NPD2971 | Approved |
0.7222 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7219 | Intermediate Similarity | NPD2421 | Approved |
0.7219 | Intermediate Similarity | NPD2420 | Approved |
0.7211 | Intermediate Similarity | NPD7667 | Clinical (unspecified phase) |
0.7209 | Intermediate Similarity | NPD4005 | Discontinued |
0.7202 | Intermediate Similarity | NPD3450 | Approved |
0.7202 | Intermediate Similarity | NPD3452 | Approved |
0.7193 | Intermediate Similarity | NPD4727 | Phase 1 |
0.7165 | Intermediate Similarity | NPD3057 | Approved |
0.716 | Intermediate Similarity | NPD3845 | Phase 1 |
0.7158 | Intermediate Similarity | NPD6297 | Approved |
0.7152 | Intermediate Similarity | NPD6028 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD6029 | Clinical (unspecified phase) |
0.7135 | Intermediate Similarity | NPD3534 | Clinical (unspecified phase) |
0.7134 | Intermediate Similarity | NPD2492 | Phase 1 |
0.7128 | Intermediate Similarity | NPD4004 | Approved |
0.7128 | Intermediate Similarity | NPD4002 | Approved |
0.7122 | Intermediate Similarity | NPD6997 | Phase 2 |
0.7118 | Intermediate Similarity | NPD3124 | Discontinued |
0.7113 | Intermediate Similarity | NPD2493 | Approved |
0.7113 | Intermediate Similarity | NPD2494 | Approved |
0.711 | Intermediate Similarity | NPD7261 | Clinical (unspecified phase) |
0.7108 | Intermediate Similarity | NPD1632 | Clinical (unspecified phase) |
0.7101 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7099 | Intermediate Similarity | NPD5718 | Phase 2 |
0.7097 | Intermediate Similarity | NPD6851 | Approved |
0.7097 | Intermediate Similarity | NPD6853 | Approved |
0.7093 | Intermediate Similarity | NPD2122 | Discontinued |
0.7092 | Intermediate Similarity | NPD4583 | Approved |
0.7092 | Intermediate Similarity | NPD4582 | Approved |
0.709 | Intermediate Similarity | NPD5525 | Clinical (unspecified phase) |
0.7086 | Intermediate Similarity | NPD7945 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD4162 | Approved |
0.7083 | Intermediate Similarity | NPD2974 | Approved |
0.7083 | Intermediate Similarity | NPD2973 | Approved |
0.7083 | Intermediate Similarity | NPD2975 | Approved |
0.7077 | Intermediate Similarity | NPD3533 | Approved |
0.7077 | Intermediate Similarity | NPD2972 | Approved |
0.7077 | Intermediate Similarity | NPD3448 | Approved |
0.7076 | Intermediate Similarity | NPD1424 | Approved |
0.707 | Intermediate Similarity | NPD3705 | Approved |
0.7066 | Intermediate Similarity | NPD1375 | Discontinued |
0.7062 | Intermediate Similarity | NPD4580 | Approved |
0.7055 | Intermediate Similarity | NPD2674 | Phase 3 |
0.7033 | Intermediate Similarity | NPD5602 | Clinical (unspecified phase) |
0.703 | Intermediate Similarity | NPD823 | Approved |
0.703 | Intermediate Similarity | NPD817 | Approved |
0.7022 | Intermediate Similarity | NPD7975 | Clinical (unspecified phase) |
0.7017 | Intermediate Similarity | NPD6688 | Approved |
0.7017 | Intermediate Similarity | NPD6687 | Approved |
0.7012 | Intermediate Similarity | NPD3110 | Approved |
0.7012 | Intermediate Similarity | NPD3109 | Approved |
0.7006 | Intermediate Similarity | NPD2161 | Phase 2 |
0.7005 | Intermediate Similarity | NPD4040 | Phase 1 |
0.6995 | Remote Similarity | NPD7047 | Phase 3 |
0.6994 | Remote Similarity | NPD3145 | Approved |
0.6994 | Remote Similarity | NPD3144 | Approved |
0.699 | Remote Similarity | NPD2491 | Approved |
0.6989 | Remote Similarity | NPD3384 | Approved |
0.6989 | Remote Similarity | NPD3383 | Approved |
0.6989 | Remote Similarity | NPD3382 | Approved |
0.6988 | Remote Similarity | NPD6896 | Approved |
0.6988 | Remote Similarity | NPD6895 | Approved |
0.6977 | Remote Similarity | NPD4123 | Phase 3 |
0.6975 | Remote Similarity | NPD5752 | Clinical (unspecified phase) |
0.6968 | Remote Similarity | NPD5087 | Clinical (unspecified phase) |
0.6966 | Remote Similarity | NPD4581 | Clinical (unspecified phase) |
0.6966 | Remote Similarity | NPD4967 | Phase 2 |
0.6966 | Remote Similarity | NPD4965 | Approved |
0.6966 | Remote Similarity | NPD4966 | Approved |
0.6959 | Remote Similarity | NPD6667 | Approved |
0.6959 | Remote Similarity | NPD6666 | Approved |
0.6959 | Remote Similarity | NPD7124 | Phase 2 |
0.6954 | Remote Similarity | NPD3686 | Approved |
0.6954 | Remote Similarity | NPD3687 | Approved |
0.6946 | Remote Similarity | NPD1753 | Discontinued |
0.6946 | Remote Similarity | NPD4108 | Discontinued |
0.6941 | Remote Similarity | NPD5754 | Discontinued |
0.6941 | Remote Similarity | NPD6331 | Phase 2 |
0.6936 | Remote Similarity | NPD6090 | Discontinued |
0.6927 | Remote Similarity | NPD4055 | Discovery |
0.6923 | Remote Similarity | NPD7037 | Approved |
0.6923 | Remote Similarity | NPD5619 | Clinical (unspecified phase) |
0.6914 | Remote Similarity | NPD6523 | Clinical (unspecified phase) |
0.6911 | Remote Similarity | NPD3808 | Clinical (unspecified phase) |
0.691 | Remote Similarity | NPD5978 | Approved |
0.691 | Remote Similarity | NPD5977 | Approved |
0.6906 | Remote Similarity | NPD7802 | Discontinued |
0.6901 | Remote Similarity | NPD2677 | Approved |
0.6901 | Remote Similarity | NPD5160 | Discontinued |
0.6901 | Remote Similarity | NPD6723 | Discontinued |
0.69 | Remote Similarity | NPD4859 | Phase 1 |
0.6897 | Remote Similarity | NPD5976 | Discontinued |
0.6895 | Remote Similarity | NPD6841 | Approved |
0.6895 | Remote Similarity | NPD6842 | Approved |
0.6895 | Remote Similarity | NPD6843 | Phase 3 |
0.6893 | Remote Similarity | NPD37 | Approved |
0.6889 | Remote Similarity | NPD6234 | Discontinued |
0.6888 | Remote Similarity | NPD4107 | Approved |
0.6885 | Remote Similarity | NPD6365 | Clinical (unspecified phase) |
0.6882 | Remote Similarity | NPD6674 | Discontinued |
0.6882 | Remote Similarity | NPD7007 | Discovery |
0.6881 | Remote Similarity | NPD5676 | Approved |
0.6879 | Remote Similarity | NPD7020 | Approved |
0.6879 | Remote Similarity | NPD7019 | Approved |
0.6864 | Remote Similarity | NPD2029 | Clinical (unspecified phase) |
0.6864 | Remote Similarity | NPD3656 | Approved |
0.6851 | Remote Similarity | NPD4666 | Phase 3 |
0.6851 | Remote Similarity | NPD2041 | Clinical (unspecified phase) |
0.6851 | Remote Similarity | NPD2042 | Clinical (unspecified phase) |
0.6839 | Remote Similarity | NPD7526 | Approved |
0.6839 | Remote Similarity | NPD52 | Approved |
0.6839 | Remote Similarity | NPD7527 | Clinical (unspecified phase) |
0.6835 | Remote Similarity | NPD2668 | Approved |
0.6835 | Remote Similarity | NPD2667 | Approved |
0.6828 | Remote Similarity | NPD3885 | Approved |
0.6813 | Remote Similarity | NPD2230 | Approved |
0.6813 | Remote Similarity | NPD2232 | Approved |
0.6813 | Remote Similarity | NPD2233 | Approved |
0.6811 | Remote Similarity | NPD7228 | Approved |
0.681 | Remote Similarity | NPD3637 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.